Trending...
- Financial Solutions Inc. Receives the 2020 Best of Sheridan Wyoming Award
- Ziggurat Technologies' Zivolve™ is Now Available for Android Users on the Google Play Store, Revolutionizing Mobile Investing Beyond the Apple iOS App
- The Business Consultant behind The First Black-owned BP
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sona Nanotech Inc. ("Sona" or "the Company") (OTC: SNANF) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Sona announced on October 29, 2020, that the FDA had denied its request for an emergency use authorization to market its rapid COVID-19 antigen test in the United States. The Company's shares fell 48% on the same day. Then on November 25, 2020, the Company announced the withdrawal of "an Interim Order authorization from Health Canada for the marketing of its rapid, COVID-19 antigen test in order to obtain more clinical data to augment its submission." Based on this news, shares of Sona fell by more than 67% on the same day.
More on The Californer
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Sona announced on October 29, 2020, that the FDA had denied its request for an emergency use authorization to market its rapid COVID-19 antigen test in the United States. The Company's shares fell 48% on the same day. Then on November 25, 2020, the Company announced the withdrawal of "an Interim Order authorization from Health Canada for the marketing of its rapid, COVID-19 antigen test in order to obtain more clinical data to augment its submission." Based on this news, shares of Sona fell by more than 67% on the same day.
More on The Californer
- Ask Sharifah Hosts Special Virtual Birthday Party in Celebration of Sharifah Hardie's 45th Birthday
- The Hottest Virtual Concert Tickets in the world The 2021 Inaugural Gospel Celebration
- Carbon Health Launches COVID-19 Vaccination Platform to Accelerate National Rollout
- Thirteen MBK Senior Living Communities Receive "2021 Best of Senior Living" Distinction
- Grassroots Advocacy Group Urges Biden Administration to Appoint a Doctoral Level Mental Health Professional to Lead SAMHSA
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Filed Under: Business
0 Comments
Latest on The Californer
- Alpha and Omega Semiconductor to Announce Fiscal Second Quarter 2021 Financial Results
- Regional Mexican stars Calibre 50 release compilation album "Las Numero 1 de Calibre 50"
- Mayor London Breed Announces Plan to Create Network of COVID-19 Vaccination Sites in San Francisco
- Simplr's Human Cloud Network Honored as One of Glassdoor's Top 50 Best Places to Work in 2021
- Ask Sharifah Adds New Podcast "The Winner's Journey Podcast with Host Viviana Puello" To Talk Show Lineup
- Mayor London Breed Names Tongo Eisen-Martin as San Francisco's Poet Laureate
- AUA College of Medicine Establishes Admissions Agreement with Mississippi Valley State University
- Dollyhood Records Signs Distribution Deal With Sony!
- La Maquinaria Norteña releases 'Deluxe' edition of "En Las Buenas y En Las Malas"
- INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Lyra Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
- Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation (BSX)
- West Coast Recording Artist, Composer and Actor, Blue Ragg$ Releases New Music & Theatrical Video
- Swaggerty's Receives Highest Possible Grade from BRC Food Safety Auditors for 8th Consecutive Year
- Agile20Reflect Festival event submission deadline extended to 27th of January
- Be an Example, Get the Covid Shot
- Aviation Capital Group Announces Closing of $750 Million of Senior Unsecured Notes
- Community Psychiatry Appoints Christopher Brengard As Chief Executive Officer
- Former CEO & Founder of Five Star Custom Foods, Acquired by Cargill, Joins CEO Coaching International
- Thiel College names Terry Eddy to Board of Trustees
- Is the Beach So Last Year?